Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...

According to the American Cancer Society, basal cell and squamous cell carcinoma are two of the most common types of skin cancer. Here are the biggest differences between the two, via the ...

The on-going Phase 1b trial (NCT# 06014086) received FDA clearance for an Investigational New Drug Application to evaluate PH-762 in the treatment of cutaneous SCC, melanoma and Merkel cell ...

Medicare covers inpatient and outpatient care for skin cancer. People with Original Medicare parts A and B or Medicare Advantage plans can expect extensive coverage, but they will likely have out ...

It is also under development for the treatment of melanoma, rhabdoid tumor, lung, bladder, breast, prostate cancers and sarcoma, extramammary paget disease (EMPD), squamous cell carcinoma, basal cell ...

Also discussed were a first-in-its-class combination treatment approval and potential indicators of increased skin cancer risk. In this study, researchers treated 37 basal cell carcinoma (BCC ...

When looking at just the relationship between the diabetes drug and skin cancer risk without adjusting for other factors, patients had 54% lower odds of developing BCC and 35% lower odds of SCC.

Non-melanoma skin cancers, including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), represent a significant public health burden, making new prevention strategies a critical area of ...

Skin cancer is the most commonly diagnosed cancer in the United States, with about 5.4 million cases of BCC and SCC reported annually, according to the American Cancer Society (ACS). Among these ...